The volume of point of care (POC) testing continues to grow steadily due to the increased
availability of easy-to-use devices, thus making it possible to deliver less costly care closer …

Effective cancer treatment requires early detection and monitoring the development
progress in a simple and affordable manner. Point-of care (POC) screening can provide a …

Objectives Cholangiocarcinoma (CCA) represents the second most common primary
hepatic malignancy. Despite tremendous research activities, the prognosis for the majority of …

Lung cancer is the leading cause of cancer-related mortality worldwide, characterized by
uncontrolled proliferation and metastasis of lung cancer cells. Tumor angiogenesis plays a …

Background As has been illustrated that long noncoding RNAs (lncRNAs) and microRNAs
(miRNAs) are potential regulators in the occurrence and progression of human cancers …

Hepatocellular carcinoma (HCC) is a prevalent malignant tumor with high morbidity and
mortality across the world. Recent findings have suggested that long noncoding (lnc) RNA …

Background Pancreatic cancer (PC) is one of the deadliest cancers about the digestive
system. Recent researches have validated that long non-coding RNAs (lncRNAs) play vital …

Background: Tumor-derived exosomal miRNAs secreted by cancer cells play significant
roles in the pathological processes of cancer, but no systematic meta-analysis has focused …

The androgen receptor (AR) is a ligand activated transcription factor that drives prostate
cancer. Since therapies that target the AR are the mainstay treatment for men with metastatic …

Background: MicroRNAs (miRNAs) could modulate gene expression at the
posttranscriptional level by promoting mRNA degradation or blocking mRNA translation …